Two New Treatments for Gonorrhea; one is available now!

Two New Treatments for Gonorrhea; one is available now!

In this episode of the Conversations with CEI, infectious disease specialist Dr. Steven Fine delves into groundbreaking advancements in the treatment of urogenital gonorrhea. The episode highlights the FDA's December 2025 approval of two innovative oral therapies that mark a significant step forward in combating this prevalent sexually transmitted infection.

Dr. Fine discusses the first of these treatments, Zoliflodacin (Nuzolvence), a novel medication specifically developed for urogenital gonorrhea. Administered as a single oral dose, it offers patients a convenient and effective option. The second treatment, Gepotidacin (Blujepa), is a versatile drug initially approved in March 2025 for urinary tract infections (UTIs). Now, it has been authorized for urogenital gonorrhea treatment, requiring two oral doses for optimal efficacy.

Throughout the episode, Dr. Fine provides insights into the clinical trials, mechanisms of action, and potential impact of these therapies on public health. He also emphasizes the importance of addressing antibiotic resistance in gonorrhea and how these new treatments may help mitigate this growing concern.

For more information, listeners can refer to the FDA's official announcement and other resources provided below.

Tune in to this episode to learn more about these exciting developments and their implications for the future of infectious disease treatment. Related Content:

Avsnitt(60)

Safe and Safer Supply for People Who Use Drugs

Safe and Safer Supply for People Who Use Drugs

The United States is in the midst of an overdose crisis that’s been exacerbated by the COVID-19 pandemic and increased toxicity of the drug supply, largely a result of adulterants like fentanyl and ot...

12 Okt 202332min

REPRIEVE: Pitavastatin to Prevent Cardiovascular Disease in HIV

REPRIEVE: Pitavastatin to Prevent Cardiovascular Disease in HIV

HIV patients are known to have up to a two-fold increase in heart-related events, compared with the general population. Could treatment with statins reduce this risk? Dr. Steven Fine, an infectious di...

14 Sep 202312min

Making a SPLASH! Long-acting Injectables for vulnerable populations with HIV

Making a SPLASH! Long-acting Injectables for vulnerable populations with HIV

The clinical innovation of antiretroviral treatment for HIV is a major public health victory that has transformed the shape of the epidemic. Healthcare professionals must remain committed to reaching ...

10 Aug 202318min

Tackling Syphilis: A Conversation with the New York State Department of Health AIDS Institute Office of Sexual Health and Epidemiology

Tackling Syphilis: A Conversation with the New York State Department of Health AIDS Institute Office of Sexual Health and Epidemiology

In this episode, Dr. Marguerite Urban chats with Drs. Rachel Hart-Malloy and Wilson Miranda from the New York State Department of Health AIDS Institute Office of Sexual Health and Epidemiology (OSHE) ...

13 Juli 202330min

Integrating Hepatitis C Treatment into Opioid Treatment Programs: The Greenwich House Story

Integrating Hepatitis C Treatment into Opioid Treatment Programs: The Greenwich House Story

Hepatitis C virus (HCV) infection is a major public health problem responsible for substantial morbidity, including cirrhosis and liver cancer, and mortality. In 2021, over 6,500 new cases were report...

8 Juni 202331min

Talking to patients about Lenacapavir (Sunlenca); the new long-acting injectable medication for HIV

Talking to patients about Lenacapavir (Sunlenca); the new long-acting injectable medication for HIV

In this episode, Dr. Steven Fine, an infectious disease specialist affiliated with the University of Rochester and Anthony Jordan Health Center explains the pros and cons behind the newly approved Len...

11 Maj 202316min

Providing Affirming Care to Transgender Youth

Providing Affirming Care to Transgender Youth

One recent study shows that only 4% of trans youth with supportive parents attempted suicide, while 57% with unsupportive parents committed suicide… In the current political landscape, transgender hea...

13 Apr 202320min

The Resurgence of Congenital Syphilis in NYS: A Look at the Past and Present to Change the Future

The Resurgence of Congenital Syphilis in NYS: A Look at the Past and Present to Change the Future

In this episode host Melinda Godfrey, a Nurse Practitioner at the University of Rochester, and Program Manager of the Congenital Syphilis Prevention Project, (part of the NYS CEI Sexual Health Center ...

9 Mars 202324min

Populärt inom Utbildning

historiepodden-se
rss-bara-en-till-om-missbruk-medberoende-2
det-skaver
alska-oss
nu-blir-det-historia
harrisons-dramatiska-historia
roda-vita-rosen
not-fanny-anymore
johannes-hansen-podcast
sektledare
rss-viktmedicinpodden
rss-foraldramotet-bring-lagercrantz
sa-in-i-sjalen
i-vantan-pa-katastrofen
allt-du-velat-veta
rss-max-tant-med-max-villman
rikatillsammans-om-privatekonomi-rikedom-i-livet
rib-podcast
rss-sjalsligt-avkladd
rss-om-vi-ska-vara-arliga